In fact, DHODH inhibitors are currently in clinical use to treat autoimmune diseases like multiple sclerosis and rheumatoid arthritis (Munier-Lehmann et al., 2013), further supporting their usefulness to dampen excessive immune responses. This evidence concerns the gene DHODH and multiple sclerosis.